check_circleStudy Completed

Dermatitis, Atopic

Bayer Identifier:
Trial_89172
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Efficacy and tolerance of once-daily methylprednisolone aceponate ointment in comparison with twice-daily hydrocortisone 17-butyrate in patients with atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

15 - N/A
  • -

  • -

Trial summary

Enrollment Goal
213
Trial Dates
February 1990 - December 1990
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Controlled, multicenter trial on efficacy and tolerance of a once-daily application of methylprednisolone aceponate (MPA) ointment in comparison with a twice-daily application of hydrocortisone 17-butyrate (HCB) in patients with atopic dermatitis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A